BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25519973)

  • 1. Epigenetic regulation of Atrophin1 by lysine-specific demethylase 1 is required for cortical progenitor maintenance.
    Zhang F; Xu D; Yuan L; Sun Y; Xu Z
    Nat Commun; 2014 Dec; 5():5815. PubMed ID: 25519973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes.
    El Mansouri FE; Nebbaki SS; Kapoor M; Afif H; Martel-Pelletier J; Pelletier JP; Benderdour M; Fahmi H
    Arthritis Res Ther; 2014 May; 16(3):R113. PubMed ID: 24886859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.
    Singh MM; Manton CA; Bhat KP; Tsai WW; Aldape K; Barton MC; Chandra J
    Neuro Oncol; 2011 Aug; 13(8):894-903. PubMed ID: 21653597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase 1 and 2 (LSD1 and LSD2).
    Mino K; Nishimura S; Ninomiya S; Tujii H; Matsumori Y; Tsuchida M; Hosoi M; Koseki K; Wada S; Hasegawa M; Sasaki R; Murakami-Yamaguchi Y; Narita H; Suzuki T; Miyata N; Mizukami T
    Biosci Biotechnol Biochem; 2014; 78(6):1010-7. PubMed ID: 25036127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranylcypromine, a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis.
    Sun Q; Ding D; Liu X; Guo SW
    Reprod Biol Endocrinol; 2016 Apr; 14():17. PubMed ID: 27062244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone demethylase LSD1-mediated repression of GATA-2 is critical for erythroid differentiation.
    Guo Y; Fu X; Jin Y; Sun J; Liu Y; Huo B; Li X; Hu X
    Drug Des Devel Ther; 2015; 9():3153-62. PubMed ID: 26124638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans-2-phenylcyclopropylamine regulates zebrafish lateral line neuromast development mediated by depression of LSD1 activity.
    He Y; Yu H; Sun S; Wang Y; Liu I; Chen Z; Li H
    Int J Dev Biol; 2013; 57(5):365-73. PubMed ID: 23873368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy.
    Schulte JH; Lim S; Schramm A; Friedrichs N; Koster J; Versteeg R; Ora I; Pajtler K; Klein-Hitpass L; Kuhfittig-Kulle S; Metzger E; Schüle R; Eggert A; Buettner R; Kirfel J
    Cancer Res; 2009 Mar; 69(5):2065-71. PubMed ID: 19223552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone demethylase LSD1 regulates neural stem cell proliferation.
    Sun G; Alzayady K; Stewart R; Ye P; Yang S; Li W; Shi Y
    Mol Cell Biol; 2010 Apr; 30(8):1997-2005. PubMed ID: 20123967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LSD1 Mediates Neuronal Differentiation of Human Fetal Neural Stem Cells by Controlling the Expression of a Novel Target Gene, HEYL.
    Hirano K; Namihira M
    Stem Cells; 2016 Jul; 34(7):1872-82. PubMed ID: 27018646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epigenetic promotion of osteogenic differentiation of human adipose-derived stem cells by the genetic and chemical blockade of histone demethylase LSD1.
    Ge W; Liu Y; Chen T; Zhang X; Lv L; Jin C; Jiang Y; Shi L; Zhou Y
    Biomaterials; 2014 Jul; 35(23):6015-25. PubMed ID: 24794925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of LSD1 inhibition on self-renewal and differentiation of human induced pluripotent stem cells.
    Yan HJ; Zhou SY; Li Y; Zhang H; Deng CY; Qi H; Li FR
    Exp Cell Res; 2016 Jan; 340(2):227-37. PubMed ID: 26748182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of lysine-specific demethylase 1 in ovarian endometriomas and its inhibition reduces cellular proliferation, cell cycle progression, and invasiveness.
    Ding D; Liu X; Guo SW
    Fertil Steril; 2014 Mar; 101(3):740-9. PubMed ID: 24388204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lysine-specific demethylase 1 by the acyclic diterpenoid geranylgeranoic acid and its derivatives.
    Sakane C; Okitsu T; Wada A; Sagami H; Shidoji Y
    Biochem Biophys Res Commun; 2014 Jan; 444(1):24-9. PubMed ID: 24406160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LSD1 co-repressor Rcor2 orchestrates neurogenesis in the developing mouse brain.
    Wang Y; Wu Q; Yang P; Wang C; Liu J; Ding W; Liu W; Bai Y; Yang Y; Wang H; Gao S; Wang X
    Nat Commun; 2016 Jan; 7():10481. PubMed ID: 26795843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation.
    Schulz-Fincke J; Hau M; Barth J; Robaa D; Willmann D; Kürner A; Haas J; Greve G; Haydn T; Fulda S; Lübbert M; Lüdeke S; Berg T; Sippl W; Schüle R; Jung M
    Eur J Med Chem; 2018 Jan; 144():52-67. PubMed ID: 29247860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity.
    Tsutsumi T; Iwao K; Hayashi H; Kirihara T; Kawaji T; Inoue T; Hino S; Nakao M; Tanihara H
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6461-6473. PubMed ID: 27893888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties.
    Wang J; Lu F; Ren Q; Sun H; Xu Z; Lan R; Liu Y; Ward D; Quan J; Ye T; Zhang H
    Cancer Res; 2011 Dec; 71(23):7238-49. PubMed ID: 21975933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1.
    Wu F; Zhou C; Yao Y; Wei L; Feng Z; Deng L; Song Y
    J Med Chem; 2016 Jan; 59(1):253-263. PubMed ID: 26652247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment.
    Duan YC; Ma YC; Qin WP; Ding LN; Zheng YC; Zhu YL; Zhai XY; Yang J; Ma CY; Guan YY
    Eur J Med Chem; 2017 Nov; 140():392-402. PubMed ID: 28987602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.